280 related articles for article (PubMed ID: 19142036)
1. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Glocker E; Bogdan C; Kist M
J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of Helicobacter pylori resistance to rifamycins.
Hays C; Burucoa C; Lehours P; Tran CT; Leleu A; Raymond J
Helicobacter; 2018 Feb; 23(1):. PubMed ID: 29168600
[TBL] [Abstract][Full Text] [Related]
4. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
Wueppenhorst N; Stueger HP; Kist M; Glocker E
J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
6. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.
Kim JM; Kim JS; Jung HC; Kim N; Kim YJ; Song IS
Antimicrob Agents Chemother; 2004 Dec; 48(12):4843-7. PubMed ID: 15561865
[TBL] [Abstract][Full Text] [Related]
7. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
Kim JM; Kim JS; Kim N; Jung HC; Song IS
J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
[TBL] [Abstract][Full Text] [Related]
8. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea.
Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS
Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270
[TBL] [Abstract][Full Text] [Related]
9. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
Furuta T; Soya Y; Sugimoto M; Shirai N; Nakamura A; Kodaira C; Nishino M; Okuda M; Okimoto T; Murakami K; Fujioka T; Hishida A
J Gastroenterol Hepatol; 2007 Nov; 22(11):1810-5. PubMed ID: 17914955
[TBL] [Abstract][Full Text] [Related]
10. High prevalence rate of Helicobacter pylori resistance to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculous mycobacteria.
Kaneko F; Suzuki H; Hasegawa N; Kurabayshi K; Saito H; Otani S; Nakamizo H; Kawata K; Miyairi M; Ishii K; Ishii H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():62-7. PubMed ID: 15298607
[TBL] [Abstract][Full Text] [Related]
11. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.
Garrido L; Toledo H
Helicobacter; 2007 Oct; 12(5):505-9. PubMed ID: 17760718
[TBL] [Abstract][Full Text] [Related]
12. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the antimycobacterial activities of rifabutin and the relationship between drug-resistance and rpoB mutations of Mycobacterium tuberculosis].
Han XQ; Huang HR; Li YJ; Yu X; Gao JT; Bi ZQ; Chu NH; Li L; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):762-5. PubMed ID: 22321711
[TBL] [Abstract][Full Text] [Related]
14. The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication.
De Francesco V; Zullo A; Ierardi E; Giorgio F; Perna F; Hassan C; Panella C; Vaira D
J Clin Gastroenterol; 2009 Apr; 43(4):386. PubMed ID: 19077730
[No Abstract] [Full Text] [Related]
15. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
16. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance.
Chen S; Li Y; Yu C
J Gastroenterol Hepatol; 2008 Jan; 23(1):126-31. PubMed ID: 18171351
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy.
De Francesco V; Margiotta M; Zullo A; Hassan C; Giorgio F; Burattini O; Stoppino G; Cea U; Pace A; Zotti M; Morini S; Panella C; Ierardi E
J Antimicrob Chemother; 2007 Apr; 59(4):783-5. PubMed ID: 17329269
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
Bogaerts P; Berhin C; Nizet H; Glupczynski Y
Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
